New AI chatbot uses medical protocols to guide patient care decisions. - News-Medical

News-Medical reported on April 25, 2026, on a new AI chatbot built to guide patient care decisions using established medical protocols. The system, named APOLLO AI, has been trained on 25 billion medical events — including hospital records and clinical visits — to identify patterns and predict disease onset. The model incorporates information about local disease prevalence, lab configurations, and medication availability to offer personalized guidance.

The article states that APOLLO AI has capabilities including predicting acute kidney injury 48 hours in advance. In tests, the AI recognizes early warning signs that might be missed by clinicians due to time constraints. The tool is currently being piloted by Barts Health NHS Trust in London for diabetes management, assisting doctors in selecting target therapies for patients with type 2 diabetes. The company, Collette Healthcare (parent of APOLLO AI), has indicated discussions with regulators regarding safety oversight.

The article quotes a company representative noting the AI's different approach from standard algorithms: employing multiple protocols simultaneously to avoid over reliance on a single source. No specific data from clinical validation studies was included in the report. The origin discussion segment mentions potential future NHS full rollout dependent on satisfactory evaluation from the Barts Health pilot results showing patient outcomes improvement.